期刊文献+

金属巯蛋白在不同年龄大鼠肝脏中的表达(英文) 被引量:1

Age-difference in hepatic metallothionein expression in rats
下载PDF
导出
摘要 目的金属硫蛋白(MT)是富含半胱氨酸的短肽,对多种重金属有高度亲和性。它对维持铜和锌的内环境稳定,防止重金属毒性和氧化应激起着重要的作用。本研究旨在探讨年龄对肝脏MT-1和MT-2的mRNA水平的影响。方法从发育(-2,1,7,14,21,28,35和60d),老龄化(28,60,180,540和800d),妊娠和哺乳大鼠肝脏中分离总RNA,并用实时定量RT-PCR法分析MT的表达。结果胎鼠(-2d)和新生鼠的MT mRNA水平高,出生7d达到高峰,随后随着年龄的增长而下降。以雄性MT-1为例,在21d断奶时其mRNA水平比-2d降低了10倍,800d时降低220倍;雄性比雌性的表达水平高。妊娠晚期MT表达减少。分娩时MT的表达反弹,但哺乳期间再次下降。结论 MT mRNA水平受一系列生理因素所影响,如发育,老龄化,性别,妊娠,哺乳和时辰。这些变化会影响人体抗衰老及对有毒物质的防御功能。 Objective This study was aimed to examine physiological variations in mRNA levels of metallothio- nein (MT) during the development, ageing, gender, pregnancy and lactation. Methods Livers from SD rats dur- ing development ( -2, 1, 7, 14, 21, 28, 35, and 60 days) and ageing (28, 60, 180, 540 and 800 days) were collected. Total RNA was isolated, and subjected to real - time RT - PCR analysis. Results The mRNA levels of MT - 1 and MT - 2 were detected in fetal livers ( - 2 days), slightly decreased at birth, but quickly peaked at 7 days of age. MTs were then decreased thereafter. For example, MT - 1 mRNA in males decreased l0 - fold at 21 days of age, and continued to decrease to 220 - fold at 800 days, as compared to 7 days of age. MT - 2 mRNA slightly increased at 60 days of age, then keeping decreases to 800 days of age. Males had higher MT mRNAs than females. In pregnancy and lactating rats, MT mRNAs decreased at late gestation clays (GD14 and GD19). MT mRNA levels were rebound at birth, but again decreased during lactation. Conclusion MT expres- sion is significantly altered by physiological factors, such as the development, ageing, sex, pregnancy and lacta- tion, which could impact the body defense against toxic stimuli and ageing.
出处 《遵义医学院学报》 2014年第1期72-76,80,共6页 Journal of Zunyi Medical University
基金 国家自然科学基金项目(NO:81160415) 贵州省科技厅药物代谢平台项目(NO:新药药理与毒理023) 贵州省教育厅研究生教育创新基地项目(NO:黔科2008-002)
关键词 金属硫蛋白 发育 老龄化 妊娠期 哺乳期 性别差异 metallothionein ageing gender pregnancy lactation development
  • 相关文献

参考文献25

  • 1Klaassen C D, Liu J, Choudhuri S. Metallothionein: an intracellular protein to protect against cadmium toxicity [ J. Annu Rev Pharmacol Toxicol, 1999,39:267 - 294.
  • 2LitJ J, Wu Q, Lu Y F, et al. New insights into generalized hepatoprotective effects of oleanolic acid: key roles of metallothionein and Nrf2 induction [ J ]- Biochem Pharma- col, 2008,76(7) :922 -928.
  • 3Nagaminc T, Nakajima K. Significance of Mctallothionein Expression in Liver Disease [ J ] Curt Pharm Biotechno], 2013, Apr 11 ( Epub ahead of print).
  • 4Jiang Y, Kang Y J. Metallothionein gene therapy tbr chemical- induced liver fibrosis in mice [ J ] Mol Ther, 2004,10(6) :1130 - 1139.
  • 5Xu X, Shi F, Huang W, et al. Metallothionein gene transfeetion verses the phenotype of activated human he- patic stellate cells [ J ]. J Pharmacol Exp Ther, 2013,346 (1) :48 -53.
  • 6Hoogenraad T U, Paradigm shift in treatment of Wilson disease: zinc therapy now treatment of choice [ J ]. Brain Dev,2006,28(3) :141 - 146.
  • 7Swindell W R. Metallothionein and the biology of aging [ J]. Ageing Res Rev, 2011 ( 1 ) : 132 - 145.
  • 8Malavolta M, Cipriano C, Costarelli L, et al. Metallothio- nein downregulation in very old age: a phenomenon asso- ciated with cellular senescence [ J ] ? Rejuvenation Res, 2008, 1 1 (2) :455 -459.
  • 9Moeehegiani E, Costarelli L, Basso A, et al. Metallothio- neins, ageing and cellular senescence: a future therapeu- tic target[J]. Curt Pharm Des, 2013,19(9):1753 - 1764.
  • 10Waalkes M P, Klaassen C D. Postnatal ontogeny of met- allothionein in various organs of the rat ]1-Toxieol hppl Pharmacol, 1984,74 ( 3 ) : 314 - 320.

同被引文献15

  • 1Marcheva B, Ramsey K M, Peek C B, et al. Circadian clocks and metabolism[ J]. Handb Exp Pharmacol, 2013, 217 : 127 - 155.
  • 2Xu Y Q, Zhang D, Jin T, et al. Diurnal variation of he-patic antioxidant gene expression in mice[J]. PLoS One, 2012, 7(8): e44237.
  • 3Lu Y F, Jin T, Xu Y, et al. Sex differences in the circa- dian variation of cytochrome p450 genes and corresponding nuclear receptors in mouse liver [ J ]. Chronobiol Int, 2013, 30(9) : 1135 - 1143.
  • 4Chiang, J Y. Bile acid metabolism and signaling [ J ]. Compr Physiol, 2013, 3(3) : 1191 - 1212.
  • 5Zhang Y K, Guo G L, Klaassen C D. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters [J]. PLoSOne,2011, 6(2): e16683.
  • 6Ma K, Xiao R, Tseng H T, et al. Circadian dysregulation disrupts bile acid homeostasis [ Jl. PLoS One, 2009, 4 (8) : e6843.
  • 7Zhang D, Jin T, Xu Y Q, et al. Diurnal - and sex - re- lated difference of metallothionein expression in mice [J]. J Circadian Rhythms, 2012, 10(1): 5.
  • 8Noshiro M, Usui E, Kawamoto T, et al. Muhiple mech- anisms regulate circadian expression of the gene for cho- lesterol 7alpha - hydroxylase (Cyp7a) , a key enzyme in hepatic bile acid biosynthesis [ J ]. J Biol Rhythms, 2007, 22 (4) : 299 - 311.
  • 9Duez H, van der Veen J N, Duhem C, et al. Regulation of bile acid synthesis by the nuclear receptor Rev - erbal- pha [ J ]. Gastroenterology, 2008, 135 (2) : 689 - 698.
  • 10Le Martelot G, Claudel T, Gatfield D, et al. REV - ER- Balpha participates in circadian SREBP signaling and bile acid homeostasis [ J ]. PLoS Biol, 2009, 7 ( 9 ) : el000181.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部